ZA899451B - Catanospermine esters in the inhibition of tumor metastasis - Google Patents
Catanospermine esters in the inhibition of tumor metastasisInfo
- Publication number
- ZA899451B ZA899451B ZA899451A ZA899451A ZA899451B ZA 899451 B ZA899451 B ZA 899451B ZA 899451 A ZA899451 A ZA 899451A ZA 899451 A ZA899451 A ZA 899451A ZA 899451 B ZA899451 B ZA 899451B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibition
- esters
- catanospermine
- tumor metastasis
- administration
- Prior art date
Links
- 206010027476 Metastases Diseases 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000005764 inhibitory process Effects 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title 1
- 230000009401 metastasis Effects 0.000 title 1
- JDVVGAQPNNXQDW-TVNFTVLESA-N Castinospermine Chemical class C1[C@H](O)[C@@H](O)[C@H](O)[C@H]2[C@@H](O)CCN21 JDVVGAQPNNXQDW-TVNFTVLESA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/284,510 US4952585A (en) | 1988-12-15 | 1988-12-15 | Castanospermine esters in the inhibition of tumor metastasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA899451B true ZA899451B (en) | 1990-09-26 |
Family
ID=23090466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA899451A ZA899451B (en) | 1988-12-15 | 1989-12-11 | Catanospermine esters in the inhibition of tumor metastasis |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4952585A (de) |
| EP (1) | EP0373663B1 (de) |
| JP (1) | JP2963476B2 (de) |
| KR (1) | KR0135278B1 (de) |
| AT (1) | ATE96320T1 (de) |
| AU (1) | AU621431B2 (de) |
| DE (1) | DE68910287T2 (de) |
| DK (1) | DK634689A (de) |
| ES (1) | ES2061912T3 (de) |
| IE (1) | IE62014B1 (de) |
| PH (1) | PH26024A (de) |
| ZA (1) | ZA899451B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5004746A (en) * | 1987-09-29 | 1991-04-02 | Merrell Dow Pharmaceuticals Inc. | Anti-retroviral castanospermine esters |
| US4970317A (en) * | 1989-08-08 | 1990-11-13 | Merrell Dow Pharmaceuticals Inc. | Process for the preparation of castanospermine esters |
| CA2287316C (en) * | 1997-05-22 | 2005-02-08 | Hoechst Marion Roussel, Inc. | Process for preparing 6-o-monoesters of castanospermine |
| US5959111A (en) * | 1997-05-22 | 1999-09-28 | Hoechst Marion Roussel, Inc. | Process for preparing 6-0-monoesters of castanospermine |
| US6013459A (en) * | 1997-06-12 | 2000-01-11 | Clinical Micro Sensors, Inc. | Detection of analytes using reorganization energy |
| JP2009545621A (ja) * | 2006-08-02 | 2009-12-24 | ユナイテッド セラピューティクス コーポレーション | ウィルス感染症のリポソーム処置 |
| KR20100127842A (ko) * | 2008-03-26 | 2010-12-06 | 유니버시티 오브 옥스퍼드 | 소포체 표적화 리포좀 |
| US8226684B2 (en) * | 2008-12-22 | 2012-07-24 | Ethicon, Inc. | Surgical sutures having collapsible tissue anchoring protrusions and methods therefor |
| US8703744B2 (en) * | 2009-03-27 | 2014-04-22 | The Chancellor, Masters And Scholars Of The University Of Oxford | Cholesterol level lowering liposomes |
| WO2017138008A2 (en) * | 2016-02-14 | 2017-08-17 | Yeda Research And Development Co. Ltd. | Methods of modulating protein exocytosis and uses of same in therapy |
| WO2018059214A1 (zh) | 2016-09-29 | 2018-04-05 | 广州君赫生物科技有限公司 | 影响saicar合成的化合物及应用 |
| US11684593B2 (en) | 2017-04-20 | 2023-06-27 | Geneheal Biotechnology Co., Ltd. | Applications of spermine and its derivative in preparation of antitumor drug |
| CA3064486C (en) | 2017-04-20 | 2023-08-01 | Geneheal Biotechnology Co., Ltd. | Applications of spermidine and its derivatives |
| US12605349B2 (en) | 2024-09-05 | 2026-04-21 | Orbus Therapeutics, Inc. | Methods of treating grade 3 astrocytoma |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4792558A (en) * | 1987-05-29 | 1988-12-20 | Merrell Dow Pharmaceuticals Inc. | Castanospermine for inhibiting tumor metastasis |
| CA1315276C (en) * | 1987-07-02 | 1993-03-30 | Paul S. Liu | Castanospermine esters and glycosides |
| US5004746A (en) * | 1987-09-29 | 1991-04-02 | Merrell Dow Pharmaceuticals Inc. | Anti-retroviral castanospermine esters |
| AU618838B2 (en) * | 1988-08-10 | 1992-01-09 | Praxis Pharmaceuticals, Inc. | Use of castanospermine as an anti-inflammatory and immunosuppressant agent |
-
1988
- 1988-12-15 US US07/284,510 patent/US4952585A/en not_active Expired - Fee Related
-
1989
- 1989-12-11 ZA ZA899451A patent/ZA899451B/xx unknown
- 1989-12-13 AU AU46707/89A patent/AU621431B2/en not_active Ceased
- 1989-12-13 KR KR1019890018449A patent/KR0135278B1/ko not_active Expired - Fee Related
- 1989-12-14 AT AT89123189T patent/ATE96320T1/de not_active IP Right Cessation
- 1989-12-14 DK DK634689A patent/DK634689A/da not_active Application Discontinuation
- 1989-12-14 DE DE89123189T patent/DE68910287T2/de not_active Expired - Fee Related
- 1989-12-14 IE IE400989A patent/IE62014B1/en not_active IP Right Cessation
- 1989-12-14 ES ES89123189T patent/ES2061912T3/es not_active Expired - Lifetime
- 1989-12-14 PH PH39704A patent/PH26024A/en unknown
- 1989-12-14 EP EP89123189A patent/EP0373663B1/de not_active Expired - Lifetime
- 1989-12-15 JP JP1324194A patent/JP2963476B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE68910287T2 (de) | 1994-03-10 |
| AU621431B2 (en) | 1992-03-12 |
| DK634689A (da) | 1990-06-16 |
| IE894009L (en) | 1990-06-15 |
| DK634689D0 (da) | 1989-12-14 |
| ES2061912T3 (es) | 1994-12-16 |
| EP0373663A2 (de) | 1990-06-20 |
| AU4670789A (en) | 1990-06-21 |
| EP0373663B1 (de) | 1993-10-27 |
| JP2963476B2 (ja) | 1999-10-18 |
| EP0373663A3 (en) | 1990-09-12 |
| US4952585A (en) | 1990-08-28 |
| KR0135278B1 (ko) | 1998-04-23 |
| IE62014B1 (en) | 1994-12-14 |
| JPH02212427A (ja) | 1990-08-23 |
| PH26024A (en) | 1992-01-24 |
| KR910011256A (ko) | 1991-08-07 |
| ATE96320T1 (de) | 1993-11-15 |
| DE68910287D1 (de) | 1993-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA899451B (en) | Catanospermine esters in the inhibition of tumor metastasis | |
| LU91173I2 (fr) | Ximelagatran, et les sels pharmaceutiquement acceptables de celui-ci (exanta). | |
| EP0449247A3 (en) | Pharmaceutical composition containing galanthamine for treating alcoholism | |
| ZA872439B (en) | Pharmaceutically acceptable salts | |
| GR3035526T3 (en) | Retroviral protease inhibitors. | |
| NZ221424A (en) | Pharmaceutical compositions contaipyrimidines | |
| ITMI921909A1 (it) | Procedimento per il rinnovo di un binario nonche' complesso di macchine | |
| EP0591421A4 (en) | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor | |
| AU3954589A (en) | The production of formate salts of nitrogenous bases | |
| ZA855264B (en) | Bisphosphonic acids and pharmaceutically acceptable salts and esters thereof | |
| CA2006267A1 (en) | Method of treating herpesviruses | |
| ITMI920045A1 (it) | Macchina posabinario per l'abbassamento controllato di un binario | |
| IL88774A0 (en) | Oxidizing salts of cubyl amines | |
| AU4385089A (en) | Method of treatment for interstitial cystitis | |
| AU1567588A (en) | A pharmaceutical combination for the prophylaxis and therapy of malaria | |
| GR3025518T3 (en) | Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus | |
| AU7071487A (en) | Chlorpheniramine therapy | |
| HUT39465A (en) | Process for producing new alkyl-amino-furanone derivatives and pharmaceutically acceptable salts | |
| IT8248610A0 (it) | Prodotto farmaceutico in polvere per la terapia dell'ulcera peptica, a base di 2,4-diammino-6-(2,5-diclo rofenil)-1,3,5-triazina o dei suoi sali farmaceuticamente accettabili | |
| ZA896334B (en) | Use of zofenopril for the treatment of rheumatoid arthritis | |
| IT1186396B (it) | Sistema per la creazione di un effetto pseudostereo nella riproduzione di suone monofonico | |
| EP0310259A3 (en) | Eperisone as a hypotensive agent | |
| GR3005387T3 (de) | ||
| GR3020162T3 (en) | A one-pot process for the preparation of alpha-L-aspartyl-L-phenylalanine methyl ester hydrochloride | |
| GB2217209B (en) | Apparatus for oral administration of a medicament |